ClinicalTrials.Veeva

Menu

Role of Leukotrienes and Adenosine in Hyperpnea-induced Bronchospasm

University of Vermont logo

University of Vermont

Status

Completed

Conditions

Asthma, Exercise Induced

Treatments

Procedure: Hyperpnea challenge

Study type

Observational

Funder types

Other

Identifiers

NCT00710255
CHRMS 08-023
Merck IISP 32710

Details and patient eligibility

About

This research is being conducted to help us better understand what causes exercise induced asthma. The investigators hypothesize that two types of chemicals, cysteinyl leukotrienes and adenosine, play an important role. The investigators will be measuring these chemicals in the exhaled breath of volunteers with exercise induced asthma as they undergo a test to mimic exercise induced asthma. The investigators will determine how the levels of these chemicals change in association with how lung function changes before, during and after an episode of exercise induced asthma.

Enrollment

8 patients

Sex

All

Ages

12 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Physician diagnosed asthma
  • Age 12-75 yrs
  • FEV1 > 70% predicted
  • HIB response > 10 %
  • No smoking last 6 mo and < 10 pack yrs
  • No URI last 4 weeks
  • No asthma exacerbation last 4 weks
  • Able to withhold SABA > 8 hrs and LABA > 24 hrs

Exclusion criteria

  • Other lung disease
  • Cardiac disease or other condition that would preclude safe participation, on theophylline or leukotriene modifiers

Trial design

8 participants in 1 patient group

Asthmatics
Description:
Asthmatics with exercise induced bronchospasm
Treatment:
Procedure: Hyperpnea challenge

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems